Wednesday, August 22, 2018
Redactor's Choice
You are here: Home / Categories / Health & Beauty (page 76)

Health & Beauty

Coty inc. and Frajo Announce A New Joint Venture In Brazil

makeup

“Brazil is one of the largest markets in the beauty industry,” said Mr. Michele Scannavini, CEO of Coty Inc. “Frajo is the right partner, sharing our passion for beauty. Together, we look forward to introducing new Coty brands into this key market.” “Joining forces with Coty and benefiting from their expertise is an important step in strengthening Frajo’s position as a leading cosmetic distributor in Brazil,” said Frank Lund, Frajo’s founder and CEO. “Coty’s unique portfolio of brands will provide our customers with more choice.” This dea... Read More »

The L’Oréal-UNESCO for Women in Science program celebrates its 15th anniversary

science

Each year, the L’Oréal-UNESCO For Women in Science program honors and brings together remarkable women whose research contributes to changing the world: global challenges from furthering our understanding of climate change and developing new energy sources, to expanding our knowledge of the human body and preserving biodiversity. In its 15 years, the L’Oréal-UNESCO For Women in Science program has developed into a recognized global action providing visibility, a public voice and support for women researchers. This initiative is a source of mot... Read More »

L’Oréal invents the luxury beauty of tomorrow in China

skin

Jean-Paul Agon, Chairman and CEO, L’Oréal Group, said “Chinese consumers are at the heart of L’Oréal’s focus and energies. A potential 250 million new Chinese consumers will be using L’Oréal’s products in the next 10 to 15 years, making China the number one contributor to our ambition of winning 1 billion new consumers and to our strategy of universalization. A significant portion of these consumers will be recruited by our Luxe brands, the segment where L’Oréal has historically led the market and where it will continue to influence the shape o... Read More »

Civil Liberties Committee rejects EU Passenger Name Record proposal

id-airport-check

A European Commission proposal to allow the use of EU air passenger name record (PNR) data in investigating serious crime and terrorist offences was rejected by Civil Liberties Committee MEPs Wednesday, by 30 votes to 25. Air carriers collect PNR data from passengers during reservation and check-in procedures for flights entering or leaving the EU. It includes the passenger’s name, address, phone number and credit card details. The Commission proposed in February 2011 to oblige air carriers to provide EU countries with the data of passengers... Read More »

50 years ago: “Pagoda” premiere in Geneva

car

The launch of the Mercedes-Benz 230 SL at the Geneva Motor Show in March 1963 caused quite a sensation: nine years after the introduction of the 300 SL (W 198) and 190 SL (W 121) sports cars in 1954, Mercedes-Benz presented the motoring world with a single successor to both these extremely successful early SL models. Known internally as the W 113, the two-seater Roadster was characterised by its exceptional comfort, excellent performance, and exemplary handling safety. The team under Chief Designer Friedrich Geiger had produced a vehicle with ... Read More »

Hans Herrmann celebrates 85th birthday

celebrate2

Legendary racing driver Hans Herrmann celebrates his 85th birthday on 23 February 2013. Born in Stuttgart, Herrmann gained international recognition during his time as a works driver for Mercedes-Benz in the years 1954 and 1955. The cars he drove for the brand back then were the post-war “Silver Arrows”, the W 196 R Grand Prix racing car and the 300 SLR (W 196 S) racing sports car. These days Hans Herrmann is regularly to be found behind the wheel of historical Mercedes-Benz competition vehicles, as a guest at any one of a variety of classic e... Read More »

New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure.

pills2

Pfizer Inc. (NYSE: PFE) today announced results from the REMINDER trial showing statistically significant risk reductions in the primary composite efficacy endpoint. The composite endpoint was defined as the time to first event of cardiovascular (CV) mortality, re-hospitalization or extended initial hospital stay due to diagnosis of heart failure (HF), sustained ventricular tachycardia or fibrillation, ejection fraction (EF) ≤40% after 1 month, or an elevation of BNP/ NT-proBNP after 1 month. The results were presented for the first time dur... Read More »

Pfizer’s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission

EU-commision

Pfizer Inc. announced today that the European Commission (EC) has granted conditional marketing authorization for BOSULIF® (bosutinib) in the European Union (EU) for the treatment of adult patients with chronic phase (CP), accelerated phase (AP) and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options. “I’m delighted the EC has approved BO... Read More »

GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis

labaratory

GlaxoSmithKline plc (GSK) today announced the start of a Phase III study to evaluate Benlysta® (belimumab) in patients with ANCA (Anti-neutrophil Cytoplasmic Antibodies) positive vasculitis – a condition that involves inflammation of the blood vessels. The multi-centre, multi-national, randomised, double-blind study will evaluate the efficacy and safety of belimumab in combination with azathioprine for the maintenance of remission in patients with a particular type of vascultitic disease called ANCA associated Vasculitis (Granulomatosis with... Read More »

Herbalife Launches New Products Including Allergen-Free Protein Shake and CoQ10 Plus Nutritional Supplement

training

Herbalife Ltd. (NYSE:HLF) announced the launch of three new products: Formula 1 Allergen-Free Protein Shake, CoQ10 Plus, and a limited-edition Formula 1 Pumpkin Spice Protein Shake. The products were introduced at the company's annual North America celebration in Los Angeles. Formula 1 Allergen-Free protein shake is a perfect nutritional solution for those with common food allergies, as it is soy, dairy and gluten free. It also contains 20 vitamins and minerals, and has nine grams of non-GMO protein from rice, pea and sesame sources and over... Read More »

Scroll To Top